Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
17.57
-0.22
(-1.24%)
At close: 4:00:02 PM EST
17.57
0.00
(0.00%)
After hours: 4:20:00 PM EST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 666.24k | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2024 |
BASSO STEPHEN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2024 |
SRIVASTAVA SAPNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
SCHLESINGER SARAH J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
SMALL DEREK A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
DIPAOLO MARK A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
HAIMOVITZ JULES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
ODYSSEAS KOSTAS D. M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 17, 2024 |
ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 14.88 per share. | Direct | 159,990 | Mar 5, 2024 |
BASSO STEPHEN Chief Financial Officer | Stock Award(Grant) at price 14.88 per share. | Direct | 179,988 | Mar 5, 2024 |
RONSHEIM MATTHEW Officer | Stock Award(Grant) at price 14.88 per share. | Direct | 189,988 | Mar 5, 2024 |
ZHEN MARIANNE Y Officer | Sale at price 13.97 - 14.01 per share. | Direct | 153,810 | Nov 15, 2023 |
ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Nov 15, 2023 |
DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.13 per share. | Indirect | 814,196 | Jun 15, 2023 |
DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.04 - 13.05 per share. | Indirect | 195,681 | Jun 6, 2023 |
DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.01 - 13.12 per share. | Indirect | 2,608,707 | May 30, 2023 |
SRIVASTAVA SAPNA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
SCHLESINGER SARAH J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
DIPAOLO MARK A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
BIRX DEBORAH L. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
HAIMOVITZ JULES Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
ODYSSEAS KOSTAS D. M.D. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 22, 2023 |
DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 13.05 - 13.48 per share. | Indirect | 1,269,375 | May 19, 2023 |
ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 15, 2023 |
DENNER ALEXANDER J Beneficial Owner of more than 10% of a Class of Security | Purchase at price 12.34 per share. | Indirect | 3,577,411 | May 11, 2023 |
ZHEN MARIANNE Y Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Apr 13, 2023 |
RAIFELD PAVEL Chief Executive Officer | Purchase at price 10.87 per share. | Direct | 32,603 | Mar 10, 2023 |
Related Tickers
ARMP Armata Pharmaceuticals, Inc.
2.0600
+3.52%
TRDA Entrada Therapeutics, Inc.
10.99
-3.00%
ASND Ascendis Pharma A/S
150.81
-0.74%
ENTA Enanta Pharmaceuticals, Inc.
7.24
-1.23%
AVBP ArriVent BioPharma, Inc.
21.96
-0.34%
TBPH Theravance Biopharma, Inc.
9.10
-0.55%
XENE Xenon Pharmaceuticals Inc.
36.02
+0.64%
DSGN Design Therapeutics, Inc.
5.04
+11.50%
ELVN Enliven Therapeutics, Inc.
19.92
+1.53%
XNCR Xencor, Inc.
14.15
-2.14%